Page last updated: 2024-09-03

brl 44408 and atipamezole

brl 44408 has been researched along with atipamezole in 1 studies

Compound Research Comparison

Studies (brl 44408)	Trials (brl 44408)	Recent Studies (post-2010) (brl 44408)	Studies (atipamezole)	Trials (atipamezole)	Recent Studies (post-2010) (atipamezole)
82	0	16	530	64	143

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Adan, RA; Janhunen, SK; la Fleur, SE	1

Other Studies

1 other study(ies) available for brl 44408 and atipamezole

Article	Year
Blocking alpha2A adrenoceptors, but not dopamine receptors, augments bupropion-induced hypophagia in rats. Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:12 Topics: Adrenergic alpha-Antagonists; Animals; Anti-Obesity Agents; Bupropion; Eating; Energy Intake; Energy Metabolism; Imidazoles; Isoindoles; Locomotion; Male; Meals; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine	2013

Article

Year

Blocking alpha2A adrenoceptors, but not dopamine receptors, augments bupropion-induced hypophagia in rats.

Obesity (Silver Spring, Md.), 2013, Volume: 21, Issue:12

Topics: Adrenergic alpha-Antagonists; Animals; Anti-Obesity Agents; Bupropion; Eating; Energy Intake; Energy Metabolism; Imidazoles; Isoindoles; Locomotion; Male; Meals; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-2; Receptors, Dopamine

2013